Clinical Trial Update: Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Cytoxan, Fludara, and Antithymocyte Globulin conditioning followed by stem cell transplant in Fanconi Anemia has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• Cytoxan (cyclophosphamide)
• Fludara (fludarabine)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fanconi Anemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-12